Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD.
Ben-Horin S, Mazor Y, Yanai H, Ron Y, Kopylov U, Yavzori M, Picard O, Fudim E, Maor Y, Lahat A, Coscas D, Eliakim R, Dotan I, Chowers Y. Ben-Horin S, et al. Among authors: coscas d. Aliment Pharmacol Ther. 2012 Mar;35(6):714-22. doi: 10.1111/j.1365-2036.2012.04997.x. Epub 2012 Jan 30. Aliment Pharmacol Ther. 2012. PMID: 22288419 Free article.
Inflammatory bowel disease: an emergent disease among Ethiopian Jews migrating to Israel.
Bar-Gil Shitrit A, Koslowsky B, Kori M, Paz K, Adar T, Israeli E, Ben-Horin S, Berdichevski T, Coscas D, Gal E, Odes S, Shaul R, Ben-Ya'acov A, Goldin E. Bar-Gil Shitrit A, et al. Among authors: coscas d. Inflamm Bowel Dis. 2015 Mar;21(3):631-5. doi: 10.1097/MIB.0000000000000311. Inflamm Bowel Dis. 2015. PMID: 25581835 Clinical Trial.
Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Diseases.
Ungar B, Kopylov U, Yavzori M, Fudim E, Picard O, Lahat A, Coscas D, Waterman M, Haj-Natour O, Orbach-Zingboim N, Mao R, Chen M, Chowers Y, Eliakim R, Ben-Horin S. Ungar B, et al. Among authors: coscas d. Clin Gastroenterol Hepatol. 2018 May;16(5):697-705.e7. doi: 10.1016/j.cgh.2017.11.050. Epub 2017 Dec 7. Clin Gastroenterol Hepatol. 2018. PMID: 29223444
Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study.
Harnik S, Abitbol CM, Haj Natour O, Yavzori M, Fudim E, Picard O, Naftali T, Broide E, Hirsch A, Selinger L, Shachar E, Yablecovitch D, Albshesh A, Coscas D, Kopylov U, Eliakim R, Ben-Horin S, Ungar B. Harnik S, et al. Among authors: coscas d. J Crohns Colitis. 2024 Mar 1;18(3):341-348. doi: 10.1093/ecco-jcc/jjad156. J Crohns Colitis. 2024. PMID: 37691574
[Gastric phytobezoar].
Sternberg A, Coscas D, Fireman Z. Sternberg A, et al. Among authors: coscas d. Harefuah. 1996 Mar 1;130(5):316-9, 359. Harefuah. 1996. PMID: 8707175 Hebrew.
[The buried gastrostomy bumper syndrome].
Fireman Z, Yunis N, Coscas D, Zamir D, Wagner Y, Sternberg A. Fireman Z, et al. Among authors: coscas d. Harefuah. 1996 Aug;131(3-4):92-3, 143. Harefuah. 1996. PMID: 8854491 Hebrew.
12 results